-
421
-
422
Refining prognostic assessment of diffuse large B-cell lymphoma: insights from multi-omics and single-cell analysis unveil SRM as a key target for regulating immunotherapy
Published 2025-01-01“…Targeting SRM may become a potential strategy for modulating immunotherapy in DLBCL, providing new insight for immunotherapy.…”
Get full text
Article -
423
-
424
-
425
Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
Published 2025-02-01“…Abstract Background For resectable adenocarcinoma of the esophagogastric junction (AEG), current treatment exploration primarily focuses on perioperative chemotherapy regimens combined with PD-1/PD-L1 inhibitors, but the long-term survival benefits of still require further investigation, and the use of upfront immunotherapy is typically restricted to patients with metastatic MSI-H (M1 MSI-H) disease due to their potential responsiveness to immunological agents. …”
Get full text
Article -
426
In vitro antitumor and immunomodulatory activities of 1,2,4-oxadiazole derivatives
Published 2025-03-01Subjects: Get full text
Article -
427
Multiple programmed cell death patterns predict the prognosis and drug sensitivity in gastric cancer
Published 2025-02-01Subjects: Get full text
Article -
428
Targeting RGMb interactions: Discovery and preclinical characterization of potent anti-RGMb antibodies blocking multiple ligand bindings
Published 2024-12-01Subjects: “…Cancer immunotherapy…”
Get full text
Article -
429
“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
Published 2024-11-01Subjects: Get full text
Article -
430
-
431
MELANOMAS, SARCOMAS, AND RENAL METASTASES IN THE LIVER: HOW TO TREAT?
Published 2025-01-01Subjects: Get full text
Article -
432
Editorial: Glycobiology and glycosylation: deciphering the secrets of glycans in humans and pathogens
Published 2025-02-01Subjects: Get full text
Article -
433
Synergistic strategies for glioblastoma treatment: CRISPR-based multigene editing combined with immune checkpoint blockade
Published 2025-02-01Subjects: Get full text
Article -
434
-
435
Hypoxia signature derived from tumor-associated endothelial cells predict prognosis in gastric cancer
Published 2025-01-01Subjects: Get full text
Article -
436
-
437
-
438
Current Advances and Future Prospects in Cancer Immunotherapeutics
Published 2023-03-01Subjects: Get full text
Article -
439
Combination of potassium oxonate with anti-PD-1 for the treatment of colorectal cancer
Published 2025-02-01Subjects: Get full text
Article -
440
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort study
Published 2025-02-01Subjects: Get full text
Article